Valicenti Advisory Services Inc. Sells 1,176 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Valicenti Advisory Services Inc. trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 31,279 shares of the medical equipment provider’s stock after selling 1,176 shares during the quarter. Intuitive Surgical makes up about 3.9% of Valicenti Advisory Services Inc.’s holdings, making the stock its 5th biggest position. Valicenti Advisory Services Inc.’s holdings in Intuitive Surgical were worth $15,366,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Ullmann Wealth Partners Group LLC increased its stake in Intuitive Surgical by 1.6% in the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock valued at $653,000 after buying an additional 21 shares during the period. One Wealth Management Investment & Advisory Services LLC increased its stake in Intuitive Surgical by 3.4% in the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock valued at $310,000 after buying an additional 23 shares during the period. Daymark Wealth Partners LLC increased its stake in Intuitive Surgical by 0.3% in the 3rd quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider’s stock valued at $3,452,000 after buying an additional 24 shares during the period. Indiana Trust & Investment Management CO increased its stake in Intuitive Surgical by 5.3% in the 2nd quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock valued at $222,000 after buying an additional 25 shares during the period. Finally, Hoxton Planning & Management LLC increased its stake in Intuitive Surgical by 4.9% in the 2nd quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock valued at $238,000 after buying an additional 25 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the stock. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Citigroup boosted their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Raymond James boosted their target price on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. Leerink Partners boosted their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Finally, Piper Sandler restated an “overweight” rating and set a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $513.74.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Brian Edward Miller sold 2,553 shares of the company’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the transaction, the executive vice president now directly owns 7,066 shares in the company, valued at approximately $3,638,990. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Intuitive Surgical news, EVP Brian Edward Miller sold 2,553 shares of the company’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the transaction, the executive vice president now directly owns 7,066 shares in the company, valued at approximately $3,638,990. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Mark Brosius sold 2,128 shares of the company’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the transaction, the senior vice president now directly owns 273 shares of the company’s stock, valued at approximately $140,595. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 52,192 shares of company stock worth $25,398,571. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Down 0.2 %

NASDAQ:ISRG opened at $511.63 on Friday. The firm has a market cap of $181.48 billion, a price-to-earnings ratio of 92.35, a price-to-earnings-growth ratio of 5.40 and a beta of 1.39. The company’s 50-day moving average is $486.71 and its two-hundred day moving average is $440.96. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $523.34.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.